| | | | | | | | | | | | | | | | | | | | | |
Ownership Document |
Schema Version: X0508 |
Document Type: 4 |
Period of Report: 12/28/23 |
Not Subject to Section 16: 0 |
Issuer: |
| Issuer CIK: 1690080 |
| Issuer Name: 180 Life Sciences Corp. |
| Issuer Trading Symbol: ATNF |
Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1832327 |
| | Owner Name: Feldmann Marc |
| Reporting Owner Address: |
| | Owner Street 1: 3000 EL CAMINO REAL, BLDG. 4, |
| | Owner Street 2: SUITE 200 |
| | Owner City: PALO ALTO |
| | Owner State: CA |
| | Owner ZIP Code: 94306 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? No |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: |
| | Other Text: |
Aff 10b5 One: 0 |
Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 12/28/23 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Timeliness: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 135,377 |
| | | Transaction Price Per Share: |
| Value: 0.0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 250,874 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
Footnotes: |
| Footnote - F1: Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3. |
Owner Signature: |
| Signature Name: /s/ Sir Marc Feldmann, Ph.D. |
| Signature Date: 12/28/23 |